These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 19101824)
1. Homozygosity of MSH2 c.1906G-->C germline mutation is associated with childhood colon cancer, astrocytoma and signs of Neurofibromatosis type I. Toledano H; Goldberg Y; Kedar-Barnes I; Baris H; Porat RM; Shochat C; Bercovich D; Pikarsky E; Lerer I; Yaniv I; Abeliovich D; Peretz T Fam Cancer; 2009; 8(3):187-94. PubMed ID: 19101824 [TBL] [Abstract][Full Text] [Related]
2. The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer. Laitman Y; Herskovitz L; Golan T; Kaufman B; Paluch SS; Friedman E Fam Cancer; 2012 Jun; 11(2):243-7. PubMed ID: 22219001 [TBL] [Abstract][Full Text] [Related]
3. Pitfalls in molecular analysis for mismatch repair deficiency in a family with biallelic pms2 germline mutations. Leenen CH; Geurts-Giele WR; Dubbink HJ; Reddingius R; van den Ouweland AM; Tops CM; van de Klift HM; Kuipers EJ; van Leerdam ME; Dinjens WN; Wagner A Clin Genet; 2011 Dec; 80(6):558-65. PubMed ID: 21204794 [TBL] [Abstract][Full Text] [Related]
4. Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity. Baris HN; Barnes-Kedar I; Toledano H; Halpern M; Hershkovitz D; Lossos A; Lerer I; Peretz T; Kariv R; Cohen S; Half EE; Magal N; Drasinover V; Wimmer K; Goldberg Y; Bercovich D; Levi Z Pediatr Blood Cancer; 2016 Mar; 63(3):418-27. PubMed ID: 26544533 [TBL] [Abstract][Full Text] [Related]
5. A636P is associated with early-onset colon cancer in Ashkenazi Jews. Guillem JG; Rapaport BS; Kirchhoff T; Kolachana P; Nafa K; Glogowski E; Finch R; Huang H; Foulkes WD; Markowitz A; Ellis NA; Offit K J Am Coll Surg; 2003 Feb; 196(2):222-5. PubMed ID: 12595050 [TBL] [Abstract][Full Text] [Related]
6. Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies. Poley JW; Wagner A; Hoogmans MM; Menko FH; Tops C; Kros JM; Reddingius RE; Meijers-Heijboer H; Kuipers EJ; Dinjens WN; Cancer; 2007 Jun; 109(11):2349-56. PubMed ID: 17440981 [TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer. Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581 [TBL] [Abstract][Full Text] [Related]
8. The spectrum of Lynch syndrome-associated germ-line mutations in Russia. Yanus GA; Akhapkina TA; Iyevleva AG; Kornilov AV; Suspitsin EN; Kuligina ES; Ivantsov AO; Aleksakhina SN; Sokolova TN; Sokolenko AP; Togo AV; Imyanitov EN Eur J Med Genet; 2020 Mar; 63(3):103753. PubMed ID: 31491536 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847 [TBL] [Abstract][Full Text] [Related]
10. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801 [TBL] [Abstract][Full Text] [Related]
11. Loss of MSH2 and MSH6 due to heterozygous germline defects in MSH3 and MSH6. Morak M; Käsbauer S; Kerscher M; Laner A; Nissen AM; Benet-Pagès A; Schackert HK; Keller G; Massdorf T; Holinski-Feder E Fam Cancer; 2017 Oct; 16(4):491-500. PubMed ID: 28528517 [TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type. Wang Q; Montmain G; Ruano E; Upadhyaya M; Dudley S; Liskay RM; Thibodeau SN; Puisieux A Hum Genet; 2003 Feb; 112(2):117-23. PubMed ID: 12522551 [TBL] [Abstract][Full Text] [Related]
13. Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management. Guillem JG; Glogowski E; Moore HG; Nafa K; Markowitz AJ; Shia J; Offit K; Ellis NA Ann Surg; 2007 Apr; 245(4):560-5. PubMed ID: 17414604 [TBL] [Abstract][Full Text] [Related]
14. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation]. Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244 [TBL] [Abstract][Full Text] [Related]
15. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158 [TBL] [Abstract][Full Text] [Related]
16. Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer. Niessen RC; Berends MJ; Wu Y; Sijmons RH; Hollema H; Ligtenberg MJ; de Walle HE; de Vries EG; Karrenbeld A; Buys CH; van der Zee AG; Hofstra RM; Kleibeuker JH Gut; 2006 Dec; 55(12):1781-8. PubMed ID: 16636019 [TBL] [Abstract][Full Text] [Related]
17. Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1. Krüger S; Kinzel M; Walldorf C; Gottschling S; Bier A; Tinschert S; von Stackelberg A; Henn W; Görgens H; Boue S; Kölble K; Büttner R; Schackert HK Eur J Hum Genet; 2008 Jan; 16(1):62-72. PubMed ID: 17851451 [TBL] [Abstract][Full Text] [Related]
18. A novel MSH2 germline mutation in homozygous state in two brothers with colorectal cancers diagnosed at the age of 11 and 12 years. Müller A; Schackert HK; Lange B; Rüschoff J; Füzesi L; Willert J; Burfeind P; Shah P; Becker H; Epplen JT; Stemmler S Am J Med Genet A; 2006 Feb; 140(3):195-9. PubMed ID: 16372347 [TBL] [Abstract][Full Text] [Related]
19. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Cunningham JM; Kim CY; Christensen ER; Tester DJ; Parc Y; Burgart LJ; Halling KC; McDonnell SK; Schaid DJ; Walsh Vockley C; Kubly V; Nelson H; Michels VV; Thibodeau SN Am J Hum Genet; 2001 Oct; 69(4):780-90. PubMed ID: 11524701 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer. Wang Q; Lasset C; Desseigne F; Saurin JC; Maugard C; Navarro C; Ruano E; Descos L; Trillet-Lenoir V; Bosset JF; Puisieux A Hum Genet; 1999; 105(1-2):79-85. PubMed ID: 10480359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]